Karina Sultankulova: Smarter D-Dimer Strategies for Safe and Efficient DVT Exclusion
Karina Sultankulova, Clinical Director at American Medical Centers, shared on LinkedIn about a recent article by Menno V Huisman and Kenneth A Bauer, published in UpToDate, adding:
”In clinical practice, ruling out Deep Vein Thrombosis (DVT) using a fixed D-dimer cutoff of 500 ng/mL often leads to over-testing, especially in older adults where baseline levels naturally rise.
Modern, evidence-based strategies allow us to safely optimize efficiency without compromising patient safety:
1. Age-adjusted cutoff
For patients >50 years old with a low/moderate pretest probability, use the following validated formula:
Age (years) x 10 ng/mL
The evidence:
Data from a multicenter prospective study of 3,205 patients showed that this approach safely ruled out DVT without compression ultrasonography (CUS).
At 3 months, there were zero VTE events in patients who fell between the fixed 500 ng/mL and their higher age-adjusted limit.
The impact: In patients ≥75 yo, it tripled the number of people who could safely avoid unnecessary imaging (16% vs. 5% using the conventional cutoff), significantly increasing specificity.
2. Pretest probability (PTP)-Adjusted Cutoff
This strategy adjusts the D-dimer threshold based on clinical risk assessment (e.g., Wells Score):
Low PTP: DVT is excluded if D-dimer is <1000 ng/mL.
Moderate PTP: DVT is excluded if D-dimer is <500 ng/mL.
The Impact: Clinical studies show this reduces the overall need for ultrasound scans by 8% to 47%, maintaining an incredibly safe missed-thrombosis rate of less than 0.6% during follow-up.
Key takeaway:
Adopting adjusted D-dimer cutoffs reduces unnecessary diagnostic imaging, lowers healthcare costs, and spares elderly patients from redundant hospital stress – all while safely excluding thromboembolic events.”
Title: Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity
Authors: Menno V Huisman, Kenneth A Bauer
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?